日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acquired resistance to molecularly targeted therapies for cancer

癌症分子靶向治疗的获得性耐药

Stubbs, Nolan M; Roady, Tyler J; Schwermann, Maximilian P; Eteshola, Elias O; MacDonald, William J; Purcell, Connor; Ryspayeva, Dinara; Verovkina, Nataliia; Tajiknia, Vida; Ghandali, Maryam; Voong, Viva; Lannigan, Alexis J; Raufi, Alexander G; Lawler, Sean; Holder, Sheldon L; Carneiro, Benedito A; Cheng, Liang; Safran, Howard P; Graff, Stephanie L; Dizon, Don S; Mani, Sendurai A; Seyhan, Attila A; Sobol, Robert W; Wong, Eric T; Chen, Clark C; Gokaslan, Ziya; Taylor, Martin S; Rivers, Brian M; El-Deiry, Wafik S

IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challenge

IGV-001细胞免疫疗法用于新诊断的胶质母细胞瘤:克服后勤挑战

Wong, Eric T; Cielo, Deus; Svokos, Konstantina; Doberstein, Curt; Sampath, Prakash; Donahue, John E; Punsoni, Michael; Rodrigues, Nuno; Rothell, Francesca; Edwards, Robert; Wang, Elaina; Riccelli, Tori; Chuck, Carlin; Shaaya, Elias A; Sastry, Rahul; Ali, Rohaid; Shao, Belinda; Abdulrazeq, Hael; Sun, Felicia W; Feler, Joshua; Santos Fontánez, Santos E; Nieves, Natalie Amaral; Dobertsein, Cody; Dailey, Jennifer; Yu, Christine; Sarangi, Sasmit; Elinzano, Heinrich; Boxerman, Jerrold L; Yu, Esther; Safran, Howard; Seyhan, Attila A; El-Deiry, Wafik S; Keith, Sharonda; Gokaslan, Ziya L; Chen, Clark C; Malik, Athar

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study

托瑞普利单抗治疗胆管癌患者的安全性和有效性:一项开放标签的 I 期研究

Naing, Aung; Mahipal, Amit; Javle, Milind; Wang, Judy; Bauer, Todd M; Bajor, David L; Elias, Anthony D; Shields, Anthony; Davis, Elizabeth; Chawla, Sant; Safran, Howard; Powderly, John D; D'Amato, Gina; Meyer, Christian F; Tang, Xiongwen; Yao, Sheng; Keegan, Patricia

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients

全球个性化癌症医学创新网络(WIN)联盟:将下一代精准肿瘤学带给患者

El-Deiry, Wafik S; Bresson, Catherine; Wunder, Fanny; Carneiro, Benedito A; Dizon, Don S; Warner, Jeremy L; Graff, Stephanie L; Azzoli, Christopher G; Wong, Eric T; Cheng, Liang; Mani, Sendurai A; Safran, Howard P; Williams, Casey; Meissner, Tobias; Solomon, Benjamin; Rubin, Eitan; Porgador, Angel; Berchem, Guy; Saintigny, Pierre; Onn, Amir; Bar, Jair; Berger, Raanan; Gantenbein, Manon; Chen, Zhen; Souza, Cristiano de Pádua; Reis, Rui Manuel Vieira; Sekacheva, Marina; Cervantes, Andrés; Dahut, William L; Annunziata, Christina M; Gober, Kerri; Musallam, Khaled M; Al-Shamsi, Humaid O; Abu-Gheida, Ibrahim; Salazar, Ramon; Limaye, Sewanti; Aref, Adel T; Reddel, Roger R; Homsi, Mohammed Ussama Al; Rouf, Abdul; Dermime, Said; Suwaidi, Jassim Al; Vlad, Catalin; Buiga, Rares; Omari, Amal Al; Abdel-Razeq, Hikmat; Oñate-Ocaña, Luis F; Nielsen, Finn Cilius; Graham, Leah; Rueter, Jens; Joshua, Anthony M; Girda, Eugenia; Libutti, Steven; Riedlinger, Gregory; Salem, Mohammed E; Farhangfar, Carol J; Mesa, Ruben A; Faltas, Bishoy M; Elemento, Olivier; Pramesh, C S; Sengar, Manju; Aoyama, Satoru; Ikeda, Sadakatsu; Berindan-Neagoe, Ioana; Gaddipati, Himabindu; Kulkarni, Mandar; Auzias, Elisabeth; Gerogianni, Maria; Wolikow, Nicolas; Istolainen, Simon; Schlafrig, Pessie; Frankel, Naftali Z; Ferraro, Amanda R; Palma, Jim; Gimenez, Alejandro Piris; Hernando-Calvo, Alberto; Felip, Enriqueta; Tsimberidou, Apostolia M; Herbst, Roy S; Tabernero, Josep; Schilsky, Richard L; Liu, Jia; Lussier, Yves; Raynaud, Jacques; Batist, Gerald; Magidi, Shai; Kurzrock, Razelle

Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT.

Imipridones ONC201/ONC206 + RT/TMZ 三联疗法 (IRT) 可减少颅内肿瘤负荷,延长原位 IDH-WT GBM 小鼠模型的生存期,并抑制 MGMT

Zhou Lanlan, Zhang Leiqing, Zhang Jun, Wu Laura Jinxuan, Zhang Shengliang, George Andrew, Hahn Marina, Safran Howard P, Chen Clark C, Seyhan Attila A, Wong Eric T, El-Deiry Wafik S

Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848

NRG肿瘤学RTOG 0848放射治疗质量保证分析

Tchelebi, Leila T; Winter, Kathryn A; Abrams, Ross A; Safran, Howard P; Regine, William F; McNulty, Susan; Wu, Abraham; Du, Kevin L; Seaward, Samantha A; Bian, Shelly X; Aljumaily, Raid; Shivnani, Anand; Knoble, Jeanna L; Crocenzi, Todd S; DiPetrillo, Thomas A; Roof, Kevin S; Crane, Christopher H; Goodman, Karyn A

Nivolumab plus ONC201 plus in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) patients: a Brown University Oncology Research Group phase Ib/II study (BrUOG379)

纳武利尤单抗联合 ONC201 治疗微卫星稳定型 (MSS) 转移性结直肠癌 (mCRC) 患者:布朗大学肿瘤研究组 Ib/II 期研究 (BrUOG379)

Almhanna, Khaldoun; Breakstone, Rimini; Raufi, Alexander; Wood, Roxanne; Webber, Amy; Dionson, Sopha; Cavanagh, Lindsay; Seyhan, Attila A; Safran, Howard; El-Deiry, Wafik

Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors

一项评估阿达沃塞替尼(AZD1775)对晚期实体瘤患者体内CYP1A2、CYP2C19和CYP3A底物药代动力学影响的I期研究

Någård, Mats; Ah-See, Mei-Lin; Strauss, James; Wise-Draper, Trisha; Safran, Howard P; Nadeau, Laura; Edenfield, William J; Lewis, Lionel D; Ottesen, Lone H; Li, Yan; Mugundu, Ganesh M

Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study

Adavosertib (AZD1775) 不会延长晚期实体瘤患者的 QTc 间期:一项 I 期开放标签研究

Någård, Mats; Ah-See, Mei-Lin; Strauss, James; Wise-Draper, Trisha; Safran, Howard P; Nadeau, Laura; Edenfield, William J; Lewis, Lionel D; Rekić, Dinko; Dota, Corina; Ottesen, Lone H; Li, Yan; Mugundu, Ganesh M

Addendum: ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma

附录:ROS1-GOPC/FIG:肝血管肉瘤中的一种新型基因融合

Marks, Eric I; Pamarthy, Sahithi; Dizon, Don; Birnbaum, Ari; Yakirevich, Evgeny; Safran, Howard; Carneiro, Benedito A